Zacks Research Issues Pessimistic Estimate for EMN Earnings

Eastman Chemical Company (NYSE:EMNFree Report) – Stock analysts at Zacks Research lowered their FY2025 EPS estimates for shares of Eastman Chemical in a report issued on Friday, November 14th. Zacks Research analyst Team now expects that the basic materials company will post earnings of $5.54 per share for the year, down from their prior estimate of $6.07. The consensus estimate for Eastman Chemical’s current full-year earnings is $8.55 per share. Zacks Research also issued estimates for Eastman Chemical’s Q1 2027 earnings at $1.75 EPS, Q2 2027 earnings at $1.75 EPS and Q3 2027 earnings at $1.89 EPS.

Eastman Chemical (NYSE:EMNGet Free Report) last posted its quarterly earnings results on Monday, November 3rd. The basic materials company reported $1.14 earnings per share for the quarter, missing the consensus estimate of $1.18 by ($0.04). The business had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.28 billion. Eastman Chemical had a return on equity of 15.24% and a net margin of 8.96%.The business’s revenue for the quarter was down 10.6% on a year-over-year basis. During the same period in the prior year, the firm earned $2.26 earnings per share. Eastman Chemical has set its FY 2025 guidance at 5.400-5.65 EPS.

A number of other research firms have also weighed in on EMN. Bank of America dropped their price objective on Eastman Chemical from $78.00 to $74.00 and set a “buy” rating for the company in a research note on Tuesday, October 14th. Weiss Ratings raised shares of Eastman Chemical from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, October 24th. KeyCorp set a $79.00 price objective on shares of Eastman Chemical and gave the company an “overweight” rating in a research report on Monday, August 4th. The Goldman Sachs Group dropped their target price on shares of Eastman Chemical from $87.00 to $65.00 and set a “neutral” rating for the company in a report on Thursday, August 7th. Finally, UBS Group reduced their price target on Eastman Chemical from $75.00 to $73.00 and set a “buy” rating on the stock in a report on Wednesday, November 5th. Eight research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, Eastman Chemical presently has an average rating of “Moderate Buy” and an average target price of $78.62.

Check Out Our Latest Research Report on Eastman Chemical

Eastman Chemical Trading Down 4.0%

Shares of EMN stock opened at $60.20 on Monday. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.68 and a quick ratio of 0.78. The business has a 50-day moving average of $62.66 and a 200 day moving average of $70.60. The stock has a market capitalization of $6.87 billion, a PE ratio of 8.45, a P/E/G ratio of 6.16 and a beta of 1.31. Eastman Chemical has a 1-year low of $56.75 and a 1-year high of $107.50.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vontobel Holding Ltd. purchased a new position in Eastman Chemical in the second quarter valued at about $392,000. Y Intercept Hong Kong Ltd boosted its stake in Eastman Chemical by 235.2% in the second quarter. Y Intercept Hong Kong Ltd now owns 66,200 shares of the basic materials company’s stock valued at $4,942,000 after acquiring an additional 46,453 shares during the period. Nisa Investment Advisors LLC increased its position in Eastman Chemical by 19.2% in the second quarter. Nisa Investment Advisors LLC now owns 67,112 shares of the basic materials company’s stock worth $5,066,000 after buying an additional 10,813 shares during the period. Bank of Montreal Can lifted its position in Eastman Chemical by 9.2% in the 2nd quarter. Bank of Montreal Can now owns 472,384 shares of the basic materials company’s stock valued at $35,268,000 after purchasing an additional 39,930 shares during the last quarter. Finally, NewSquare Capital LLC boosted its position in shares of Eastman Chemical by 92.2% during the second quarter. NewSquare Capital LLC now owns 80,429 shares of the basic materials company’s stock worth $6,005,000 after buying an additional 38,572 shares during the period. Institutional investors own 83.65% of the company’s stock.

Eastman Chemical Company Profile

(Get Free Report)

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.

Recommended Stories

Earnings History and Estimates for Eastman Chemical (NYSE:EMN)

Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.